Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
61 hedge funds and large institutions have $278M invested in Syneron Medical Ltd in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 15 closing their positions.
14% less funds holding
Funds holding: 71 → 61 (-10)
16% less capital invested
Capital invested by funds: $331M → $278M (-$52.8M)
35% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 23
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$5.83M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$5.43M |
| 3 |
HC
Hourglass Capital
Houston,
Texas
|
+$2.95M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.47M |
| 5 |
HM
HealthCor Management
New York
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAD
Craig A. Drill
|
-$2.36M |
| 2 |
JP Morgan Chase
New York
|
-$1.78M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.35M |
| 4 |
PIM
Profit Investment Management
North Bethesda,
Maryland
|
-$1.25M |
| 5 |
Renaissance Technologies
New York
|
-$786K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
AllianceBernstein
Nashville,
Tennessee
| – | -$3K | -211 | Closed |
|
ELOS Hedge Fund Activity: Q2 2014 in Review
61 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2014, worth a combined $278M — down 16% from $331M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ELOS and 5 opened new positions — a net loss of 10 holders — while 23 trimmed existing stakes and 15 added.
The largest buyer was North Tide Capital, adding an estimated $5.83M. The largest seller was Craig A. Drill, exiting entirely with an estimated $2.36M sold.
- 61 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2014, down from 71 in Q1 2014.
- Funds reported $278M of Syneron Medical Ltd stock for Q2 2014, down 16% quarter-over-quarter.
- 5 funds opened new Syneron Medical Ltd positions in Q2 2014 and 15 closed out, a net change of -10 holders.
- The largest Syneron Medical Ltd buyer in Q2 2014 was North Tide Capital, an estimated $5.83M added.
- The largest Syneron Medical Ltd seller in Q2 2014 was Craig A. Drill, an estimated $2.36M sold.
Based on aggregated 13F filings for Q2 2014.